These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1154 related articles for article (PubMed ID: 28030842)
1. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma. Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842 [TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma. Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia induced Bcl-2/Twist1 complex promotes tumor cell invasion in oral squamous cell carcinoma. Duan Y; He Q; Yue K; Si H; Wang J; Zhou X; Wang X Oncotarget; 2017 Jan; 8(5):7729-7739. PubMed ID: 28032603 [TBL] [Abstract][Full Text] [Related]
4. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma. Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934 [TBL] [Abstract][Full Text] [Related]
5. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages. Ye X; Zhang J; Lu R; Zhou G Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032 [TBL] [Abstract][Full Text] [Related]
6. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998 [TBL] [Abstract][Full Text] [Related]
7. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma. Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595 [TBL] [Abstract][Full Text] [Related]
8. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion. Park J; Zhang X; Lee SK; Song NY; Son SH; Kim KR; Shim JH; Park KK; Chung WY J Clin Invest; 2019 Dec; 129(12):5381-5399. PubMed ID: 31487270 [TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492 [TBL] [Abstract][Full Text] [Related]
10. Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma. Cannonier SA; Gonzales CB; Ely K; Guelcher SA; Sterling JA Oncotarget; 2016 Nov; 7(46):76062-76075. PubMed ID: 27738315 [TBL] [Abstract][Full Text] [Related]
11. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells. Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1. Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630 [TBL] [Abstract][Full Text] [Related]
13. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma. Takayama Y; Mori T; Nomura T; Shibahara T; Sakamoto M Int J Oncol; 2010 Jun; 36(6):1387-94. PubMed ID: 20428761 [TBL] [Abstract][Full Text] [Related]
14. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459 [TBL] [Abstract][Full Text] [Related]
15. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma. Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674 [TBL] [Abstract][Full Text] [Related]
17. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma. Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946 [TBL] [Abstract][Full Text] [Related]
18. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. Martin CK; Dirksen WP; Shu ST; Werbeck JL; Thudi NK; Yamaguchi M; Wolfe TD; Heller KN; Rosol TJ Oral Oncol; 2012 Jun; 48(6):491-9. PubMed ID: 22265717 [TBL] [Abstract][Full Text] [Related]
19. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway. Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938 [TBL] [Abstract][Full Text] [Related]